SLC5A2 and chronic kidney disease: In addition, we expect that future studies will investigate whether the prevention of further CKD-induced atrial remodelling using mineralocorticoid receptor antagonists and sodium-glucose cotransporter 2 inhibitors may also improve rhythm outcomes after catheter ablation.23,33